Gastrointestinal hormones as potential adjuvant treatment of exocrine pancreatic adenocarcinoma

Author： Fisher William   Muscarella Peter   Boros Laszlo   Schirmer William  

Publisher： Humana Press, Inc

ISSN： 1537-3649

Source： International Journal of Gastrointestinal Cancer, Vol.24, Iss.3, 1998-12, pp. : 169-180

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evidence-Based Adjuvant Treatment of Resectable Pancreatic Adenocarcinoma

By Loi Sherene  

American Journal of Cancer, Vol. 4, Iss. 3, 2005-01 ,pp. : 159-168

Adis International

Access to resources Recommend Favorite

Current state of adjuvant therapy in resected pancreatic adenocarcinoma

By Bergenfeldt Magnus   Albertsson Maria  

Acta Oncologica, Vol. 45, Iss. 2, 2006-03 ,pp. : 124-135

Informa Healthcare

Access to resources Recommend Favorite

Locoregional Chemotherapy for Adjuvant Treatment of Colorectal Adenocarcinoma

By Penna C.   Nordlinger B.  

European Journal of Cancer, Vol. 32, Iss. 7, 1996-06 ,pp. : 1117-1122

Elsevier

Access to resources Recommend Favorite

Immunoelectron Study of Pancreatic Carcinomas Using Antibodies to Gastrointestinal Hormones

By Seretis E. C.   Gavriil A. N.   Golematis V. C.   Voloudakis-Baltatzis I. E.  

Ultrastructural Pathology, Vol. 31, Iss. 4, 2007-08 ,pp. : 303-314

Informa Healthcare

Access to resources Recommend Favorite

Latexin exhibits tumor-suppressor potential in pancreatic ductal adenocarcinoma

By                      

Oncology Reports, Vol. 35, Iss. 1, 2016-01 ,pp. : 50-58

Spandidos Publications

Access to resources Recommend Favorite